DCVC

DCVC is a venture capital firm based in Palo Alto, California, founded in 2010. The firm specializes in investing in seed and early-stage companies across various sectors, including artificial intelligence, exascale computing, climate technology, engineering, materials science, robotics, space, water, biology, defense, and security. With a team of experienced venture capitalists, technology entrepreneurs, and engineers, DCVC has a proven track record, having invested in over 150 companies and achieved 40 significant exits. In 2018, the firm expanded its focus with the launch of DCVC Bio, which invests in early-stage startups in computational biology. This branch targets innovations in synthetic biology, medicine, and agriculture, emphasizing teams that leverage advancements in genetic sequencing, artificial intelligence, and automation to drive transformative changes in the life sciences. Both divisions of DCVC are committed to supporting entrepreneurs who are advancing technology and creating impactful solutions in their respective fields.

Zachary Bogue

Co-Founder and Managing Partner

Chris Boshuizen

Operating Partner

Jack Buendorf

Associate

Kelly Chen

Partner

Alan Cohen

General Partner

Michael Driscoll Ph.D

Founding Partner

Anna Fokina

Investment Director

John Hamer

Managing Partner

MayC Huang

Investor

Gloria Lau

Equity Partner

Patrick Mccauley

Operating Partner

Matt O'Connell

Operating Partner

Matthew Ocko

Co-Managing Partner and Co-Founder

Joe Oleynik

Associate

Luca Parolari

Senior Associate, DCVC Bio

Jason Pontin

Partner

Spencer Punter

Partner, COO

Kristen Rocca

Principal

Monica Rogati

Equity Partner

Merline Saintil

Operating Partner

Richard Waines

Associate, DCVC Bio

Past deals in AgTech

Halter

Series C in 2023
Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in advanced agricultural technology. The company designs GPS-enabled, solar-powered collars for cows, allowing farmers to monitor and manage their herds more efficiently. Utilizing a simple tablet application, farmers can remotely establish geographic boundaries, creating virtual fences to guide their animals without physical herding. Halter's system not only enhances productivity but also collects behavioral data to alert farmers about critical events, such as when cows are in heat, lame, or nearing calving. By optimizing herd management, Halter aims to modernize dairy farming practices and improve animal welfare.

CH4 Global

Series A in 2021
CH4 Global Inc. is a holding company based in San Francisco, California, that specializes in producing seaweed bio-products aimed at reducing methane emissions from livestock. Founded in 2019, the company focuses on Asparagopsis armata, a seaweed supplement that has been scientifically proven to decrease methane emissions from ruminant animals such as cows, goats, sheep, and deer by up to 90%. By leveraging advanced aquaculture techniques, CH4 Global provides innovative solutions to mitigate greenhouse gases on a global scale, with its products offered through subsidiaries in the United States, Australia, New Zealand, and the Pacific. The company has attracted investment from family offices and private investors, as well as support from government organizations, to further its mission of addressing climate change while providing benefits like carbon credits for farmers and food producers.

Genedit

Series A in 2021
GenEdit Inc. is a biotechnology company based in Berkeley, California, established in 2016. It specializes in developing innovative genome editing technologies, particularly using the CRISPR/Cas9 system for therapeutic gene editing. The company focuses on addressing the challenges associated with the delivery of gene therapies through its proprietary non-viral nanoparticle-based delivery platform. This platform enables more efficient and accurate delivery of CRISPR components, enhancing the potential for curative treatments for genetic diseases. By systematically screening a library of nanoparticles, GenEdit aims to improve the safety and effectiveness of gene editing, making it a promising solution for a wide range of therapeutic applications.

Earth AI

Seed Round in 2021
Earth AI Pty Ltd. is an innovative mineral exploration company based in Parramatta, Australia, founded in 2016. The company specializes in developing artificial intelligence-based software that identifies potential areas of mineralization in remote locations lacking pre-existing geological data. By using AI mineral targeting technology, Earth AI provides geologists with location suggestions for mineral exposure and automatically generates detailed geological maps from satellite, geophysical, and geochemical datasets. This approach allows Earth AI to discover new metal deposits valued between $10 million and $100 million significantly faster and at a lower cost than traditional methods. The company's field-proven system is reported to be 50 times more successful in identifying mineralized prospects and achieves five times cheaper field operations through hardware automation and streamlined processes. Earth AI focuses on various metals, including copper, lead, zinc, nickel, cobalt, vanadium, and rare earth elements, effectively enhancing the chances of successful mineral discovery while minimizing operational risks and expenses.

Pivot Bio

Series D in 2021
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Strateos

Series B in 2021
Strateos operates a robotic cloud laboratory that automates chemistry, biology, and tissue analysis to enhance drug discovery processes. By integrating advanced robotics, control systems, and sophisticated imaging and analytics software, Strateos allows pharmaceutical companies to discover new drug candidates more efficiently. The company emerged from a merger between Transcriptic, known for its pioneering robotic cloud laboratory platform, and 3Scan, which specialized in using automation and machine learning to analyze tissue samples. This combination enables Strateos to provide a comprehensive suite of technologies designed to streamline the drug discovery and early development phases. By transforming life science methodologies into data-driven processes, Strateos aims to create a more efficient and cost-effective approach to scientific research, positioning itself as a valuable partner to biotechnology firms seeking to innovate in the field.

Halter

Series B in 2021
Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in advanced agricultural technology. The company designs GPS-enabled, solar-powered collars for cows, allowing farmers to monitor and manage their herds more efficiently. Utilizing a simple tablet application, farmers can remotely establish geographic boundaries, creating virtual fences to guide their animals without physical herding. Halter's system not only enhances productivity but also collects behavioral data to alert farmers about critical events, such as when cows are in heat, lame, or nearing calving. By optimizing herd management, Halter aims to modernize dairy farming practices and improve animal welfare.

Gro Intelligence

Series B in 2021
Gro Intelligence is a data analytics platform focused on the global agriculture industry, utilizing artificial intelligence and machine learning to analyze a wide range of agricultural data. Founded in 2014 and headquartered in New York, with an additional office in Nairobi, the company aggregates and processes both structured and unstructured data from diverse sources, including satellite imagery and trade reports. By employing proprietary algorithms, Gro Intelligence generates predictive models that provide insights into weather patterns, trade flows, pricing dynamics, and production metrics. This enables financial institutions, corporations, and public sector entities to make informed decisions based on comprehensive and timely information. The company has attracted significant investment, raising $20 million to date from notable investors. With approximately 50 employees, Gro Intelligence aims to bridge data gaps within the agricultural sector, enhancing productivity and access to capital for stakeholders across the ecosystem.

Zymergen

Series D in 2020
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. The company integrates automation, machine learning, and genomics to enhance its platform, which aids in optimizing microbial strains and improving the efficiency of production processes. By leveraging big data and artificial intelligence, Zymergen collaborates with clients to engineer novel molecules from microbes, thereby advancing product development. Founded in 2013 and headquartered in Emeryville, California, Zymergen also has offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, enabling it to serve a global clientele effectively.

Atomwise

Series B in 2020
Atomwise, Inc. specializes in deep learning artificial intelligence technology aimed at small molecule drug discovery. The company leverages its proprietary AI platform, AtomNet, which contains over 16 billion molecules for virtual screening, to enhance the speed and accuracy of drug discovery processes. This technology employs a statistical approach to predict the binding of small molecules to proteins, aiding in drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise collaborates on numerous projects each year with major pharmaceutical and agrochemical companies, as well as over 200 universities and hospitals across 40 countries. Founded in 2012 and based in San Francisco, Atomwise was previously known as Chematria, Inc. before rebranding in 2015.

Atomwise

Series B in 2020
Atomwise, Inc. specializes in deep learning artificial intelligence technology aimed at small molecule drug discovery. The company leverages its proprietary AI platform, AtomNet, which contains over 16 billion molecules for virtual screening, to enhance the speed and accuracy of drug discovery processes. This technology employs a statistical approach to predict the binding of small molecules to proteins, aiding in drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise collaborates on numerous projects each year with major pharmaceutical and agrochemical companies, as well as over 200 universities and hospitals across 40 countries. Founded in 2012 and based in San Francisco, Atomwise was previously known as Chematria, Inc. before rebranding in 2015.

Pivot Bio

Series C in 2020
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Halter

Series B in 2020
Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in advanced agricultural technology. The company designs GPS-enabled, solar-powered collars for cows, allowing farmers to monitor and manage their herds more efficiently. Utilizing a simple tablet application, farmers can remotely establish geographic boundaries, creating virtual fences to guide their animals without physical herding. Halter's system not only enhances productivity but also collects behavioral data to alert farmers about critical events, such as when cows are in heat, lame, or nearing calving. By optimizing herd management, Halter aims to modernize dairy farming practices and improve animal welfare.

Pyka

Seed Round in 2019
Pyka, Inc. specializes in the development of autonomous electric aircraft, primarily aimed at the agricultural sector. Founded in 2016 and headquartered in Oakland, California, the company creates aircraft designed for the application and spraying of chemicals on agricultural lands. These planes are equipped with advanced technology, including autonomous flight controllers, onboard sensors, and systems for obstacle detection and path planning. This enables them to navigate various terrains and perform hyper-short takeoffs and landings from nearly any location. Pyka's aircraft are notable for being the first certified electric autonomous airplanes to operate commercially, providing an innovative and efficient alternative to traditional ground transit in agriculture.

Pyka

Seed Round in 2019
Pyka, Inc. specializes in the development of autonomous electric aircraft, primarily aimed at the agricultural sector. Founded in 2016 and headquartered in Oakland, California, the company creates aircraft designed for the application and spraying of chemicals on agricultural lands. These planes are equipped with advanced technology, including autonomous flight controllers, onboard sensors, and systems for obstacle detection and path planning. This enables them to navigate various terrains and perform hyper-short takeoffs and landings from nearly any location. Pyka's aircraft are notable for being the first certified electric autonomous airplanes to operate commercially, providing an innovative and efficient alternative to traditional ground transit in agriculture.

Verdant Robotics

Seed Round in 2019
Verdant Robotics, Inc. specializes in the development of artificial intelligence-based robotic solutions aimed at enhancing agricultural practices. Founded in 2018 and headquartered in Hayward, California, the company offers technology that digitally maps farms over time and space, allowing for the automatic tracking and treatment of individual plants. By utilizing robotics, computer vision, and machine learning, Verdant Robotics aims to improve grower profits through precise and efficient agricultural methods. In addition to its technological offerings, the company provides autonomous farming services to support modern agricultural needs.

Smartex

Seed Round in 2019
Smartex focuses on addressing significant challenges in the textile industry by leveraging advanced AI technology, specifically machine learning and computer vision. The company has developed a hardware-enabled software solution that detects textile defects and irregularities in real time. By implementing this innovative system, Smartex can halt production when defects are identified, thereby minimizing defective output and reducing textile waste. This proactive approach not only enhances production efficiency but also contributes to sustainability by lowering carbon dioxide emissions, energy consumption, and water usage. Moreover, Smartex provides factories with a user interface to monitor production statistics, further improving operational insights and decision-making capabilities.

Earth AI

Seed Round in 2019
Earth AI Pty Ltd. is an innovative mineral exploration company based in Parramatta, Australia, founded in 2016. The company specializes in developing artificial intelligence-based software that identifies potential areas of mineralization in remote locations lacking pre-existing geological data. By using AI mineral targeting technology, Earth AI provides geologists with location suggestions for mineral exposure and automatically generates detailed geological maps from satellite, geophysical, and geochemical datasets. This approach allows Earth AI to discover new metal deposits valued between $10 million and $100 million significantly faster and at a lower cost than traditional methods. The company's field-proven system is reported to be 50 times more successful in identifying mineralized prospects and achieves five times cheaper field operations through hardware automation and streamlined processes. Earth AI focuses on various metals, including copper, lead, zinc, nickel, cobalt, vanadium, and rare earth elements, effectively enhancing the chances of successful mineral discovery while minimizing operational risks and expenses.

Sabanto

Seed Round in 2019
Sabanto is a farming-as-a-service company that specializes in row-crop field operations through the use of low-cost autonomous systems. It offers a technology platform that provides comprehensive agricultural services, utilizing advanced autonomous equipment to manage farming tasks efficiently. By enabling supervised operation from a central location, Sabanto allows farmers to monitor and control their farmlands effectively, streamlining agricultural processes and enhancing productivity.

Sabanto

Seed Round in 2019
Sabanto is a farming-as-a-service company that specializes in row-crop field operations through the use of low-cost autonomous systems. It offers a technology platform that provides comprehensive agricultural services, utilizing advanced autonomous equipment to manage farming tasks efficiently. By enabling supervised operation from a central location, Sabanto allows farmers to monitor and control their farmlands effectively, streamlining agricultural processes and enhancing productivity.

Strateos

Venture Round in 2019
Strateos operates a robotic cloud laboratory that automates chemistry, biology, and tissue analysis to enhance drug discovery processes. By integrating advanced robotics, control systems, and sophisticated imaging and analytics software, Strateos allows pharmaceutical companies to discover new drug candidates more efficiently. The company emerged from a merger between Transcriptic, known for its pioneering robotic cloud laboratory platform, and 3Scan, which specialized in using automation and machine learning to analyze tissue samples. This combination enables Strateos to provide a comprehensive suite of technologies designed to streamline the drug discovery and early development phases. By transforming life science methodologies into data-driven processes, Strateos aims to create a more efficient and cost-effective approach to scientific research, positioning itself as a valuable partner to biotechnology firms seeking to innovate in the field.

Agnostiq

Pre Seed Round in 2019
Agnostiq Inc. is a Toronto-based enterprise technology startup that specializes in security software for quantum cloud computing. Founded in 2018, the company offers solutions designed to ensure the privacy of data and algorithms while enabling users to experiment with quantum processors over the cloud. Agnostiq's software is compatible with current quantum hardware, allowing users to adjust security levels based on their specific needs. By integrating with existing software development kits, Agnostiq provides cross-platform solutions that cater to various cloud service providers. This innovative approach allows privacy-sensitive users to leverage the advantages of quantum computing without compromising their proprietary information.

Zymergen

Series C in 2018
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. The company integrates automation, machine learning, and genomics to enhance its platform, which aids in optimizing microbial strains and improving the efficiency of production processes. By leveraging big data and artificial intelligence, Zymergen collaborates with clients to engineer novel molecules from microbes, thereby advancing product development. Founded in 2013 and headquartered in Emeryville, California, Zymergen also has offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, enabling it to serve a global clientele effectively.

Genedit

Seed Round in 2018
GenEdit Inc. is a biotechnology company based in Berkeley, California, established in 2016. It specializes in developing innovative genome editing technologies, particularly using the CRISPR/Cas9 system for therapeutic gene editing. The company focuses on addressing the challenges associated with the delivery of gene therapies through its proprietary non-viral nanoparticle-based delivery platform. This platform enables more efficient and accurate delivery of CRISPR components, enhancing the potential for curative treatments for genetic diseases. By systematically screening a library of nanoparticles, GenEdit aims to improve the safety and effectiveness of gene editing, making it a promising solution for a wide range of therapeutic applications.

Genedit

Seed Round in 2018
GenEdit Inc. is a biotechnology company based in Berkeley, California, established in 2016. It specializes in developing innovative genome editing technologies, particularly using the CRISPR/Cas9 system for therapeutic gene editing. The company focuses on addressing the challenges associated with the delivery of gene therapies through its proprietary non-viral nanoparticle-based delivery platform. This platform enables more efficient and accurate delivery of CRISPR components, enhancing the potential for curative treatments for genetic diseases. By systematically screening a library of nanoparticles, GenEdit aims to improve the safety and effectiveness of gene editing, making it a promising solution for a wide range of therapeutic applications.

Entocycle

Seed Round in 2018
Entocycle Ltd is a London-based company that specializes in producing insect-based protein for animal feed. Founded in 2014, it raises black soldier flies in an automated system designed to monitor their development and environmental conditions. By utilizing food waste from farms, factories, and the catering industry, Entocycle effectively converts organic waste into sustainable protein biomass. This approach not only provides a cost-effective alternative to traditional feed sources like soymeal and fishmeal but also addresses environmental concerns associated with conventional agriculture. The company's technology enables efficient vertical farming, allowing for large-scale production of protein with significantly reduced land and water usage. Entocycle serves various sectors, including feed suppliers, retailers, and the agricultural industry, promoting a more sustainable and resource-efficient method of livestock feeding.

Supplant

Seed Round in 2018
Cambridge Glycoscience is a biotechnology company based in London, United Kingdom, founded in 2017. The company specializes in developing sugar-free ingredients for the food industry, focusing on creating natural food components derived from agricultural resources. Their innovative products enable food manufacturers to reduce sugar content, enhance fiber levels, and improve gut health-promoting qualities in food items. By leveraging biotechnology, Cambridge Glycoscience aims to support healthier eating options and contribute to the evolving landscape of food production.

Halter

Series A in 2018
Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in advanced agricultural technology. The company designs GPS-enabled, solar-powered collars for cows, allowing farmers to monitor and manage their herds more efficiently. Utilizing a simple tablet application, farmers can remotely establish geographic boundaries, creating virtual fences to guide their animals without physical herding. Halter's system not only enhances productivity but also collects behavioral data to alert farmers about critical events, such as when cows are in heat, lame, or nearing calving. By optimizing herd management, Halter aims to modernize dairy farming practices and improve animal welfare.

ENOUGH

Series A in 2018
ENOUGH, formerly known as 3fbio Ltd., is a technology spin-out from the University of Strathclyde, established to develop and commercialize innovative patented technology for the production of mycoprotein, a meat-free food product. The company employs integrated fermentation processes that combine the production of mycoprotein with existing bio-refinery operations, which also generate bioethanol and animal feed as co-products. By utilizing glucose syrup as feedstock for mycoprotein and carbohydrate feedstock for bioethanol, ENOUGH aims to enhance production economics while promoting sustainable food solutions. Incorporated in 2015 and based in Glasgow, United Kingdom, the company focuses on transforming the food, fuel, and feed sectors through its advanced production methods.

Atomwise

Series A in 2018
Atomwise, Inc. specializes in deep learning artificial intelligence technology aimed at small molecule drug discovery. The company leverages its proprietary AI platform, AtomNet, which contains over 16 billion molecules for virtual screening, to enhance the speed and accuracy of drug discovery processes. This technology employs a statistical approach to predict the binding of small molecules to proteins, aiding in drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise collaborates on numerous projects each year with major pharmaceutical and agrochemical companies, as well as over 200 universities and hospitals across 40 countries. Founded in 2012 and based in San Francisco, Atomwise was previously known as Chematria, Inc. before rebranding in 2015.

Pyka

Pre Seed Round in 2017
Pyka, Inc. specializes in the development of autonomous electric aircraft, primarily aimed at the agricultural sector. Founded in 2016 and headquartered in Oakland, California, the company creates aircraft designed for the application and spraying of chemicals on agricultural lands. These planes are equipped with advanced technology, including autonomous flight controllers, onboard sensors, and systems for obstacle detection and path planning. This enables them to navigate various terrains and perform hyper-short takeoffs and landings from nearly any location. Pyka's aircraft are notable for being the first certified electric autonomous airplanes to operate commercially, providing an innovative and efficient alternative to traditional ground transit in agriculture.

Gro Intelligence

Series A in 2017
Gro Intelligence is a data analytics platform focused on the global agriculture industry, utilizing artificial intelligence and machine learning to analyze a wide range of agricultural data. Founded in 2014 and headquartered in New York, with an additional office in Nairobi, the company aggregates and processes both structured and unstructured data from diverse sources, including satellite imagery and trade reports. By employing proprietary algorithms, Gro Intelligence generates predictive models that provide insights into weather patterns, trade flows, pricing dynamics, and production metrics. This enables financial institutions, corporations, and public sector entities to make informed decisions based on comprehensive and timely information. The company has attracted significant investment, raising $20 million to date from notable investors. With approximately 50 employees, Gro Intelligence aims to bridge data gaps within the agricultural sector, enhancing productivity and access to capital for stakeholders across the ecosystem.

Plenty

Series B in 2017
Plenty Unlimited Inc. is a vertical farming company based in South San Francisco, California, that specializes in producing fresh and nutritious fruits and vegetables. Founded in 2014, Plenty operates an indoor vertical farm that employs innovative farming techniques to cultivate crops without the use of pesticides or genetically modified organisms. The company's farming systems are designed to be highly efficient, using 99% less water compared to traditional farming methods while generating zero fertilizer runoff. Plenty is committed to delivering clean, healthy produce to consumers and distributes its products to local stores. Additionally, the company has a research and development farm located in Laramie, Wyoming, aimed at further enhancing its agricultural practices.

ENOUGH

Seed Round in 2017
ENOUGH, formerly known as 3fbio Ltd., is a technology spin-out from the University of Strathclyde, established to develop and commercialize innovative patented technology for the production of mycoprotein, a meat-free food product. The company employs integrated fermentation processes that combine the production of mycoprotein with existing bio-refinery operations, which also generate bioethanol and animal feed as co-products. By utilizing glucose syrup as feedstock for mycoprotein and carbohydrate feedstock for bioethanol, ENOUGH aims to enhance production economics while promoting sustainable food solutions. Incorporated in 2015 and based in Glasgow, United Kingdom, the company focuses on transforming the food, fuel, and feed sectors through its advanced production methods.

Strateos

Venture Round in 2016
Strateos operates a robotic cloud laboratory that automates chemistry, biology, and tissue analysis to enhance drug discovery processes. By integrating advanced robotics, control systems, and sophisticated imaging and analytics software, Strateos allows pharmaceutical companies to discover new drug candidates more efficiently. The company emerged from a merger between Transcriptic, known for its pioneering robotic cloud laboratory platform, and 3Scan, which specialized in using automation and machine learning to analyze tissue samples. This combination enables Strateos to provide a comprehensive suite of technologies designed to streamline the drug discovery and early development phases. By transforming life science methodologies into data-driven processes, Strateos aims to create a more efficient and cost-effective approach to scientific research, positioning itself as a valuable partner to biotechnology firms seeking to innovate in the field.

Zymergen

Series B in 2016
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. The company integrates automation, machine learning, and genomics to enhance its platform, which aids in optimizing microbial strains and improving the efficiency of production processes. By leveraging big data and artificial intelligence, Zymergen collaborates with clients to engineer novel molecules from microbes, thereby advancing product development. Founded in 2013 and headquartered in Emeryville, California, Zymergen also has offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, enabling it to serve a global clientele effectively.

Verdigris

Series A in 2016
Verdigris Technologies, Inc. specializes in developing software solutions for electricity monitoring and management in commercial facilities. The company's primary product, Verdigris Energy Tracker, identifies operational inefficiencies, automates building management, and predicts demand peaks while detecting equipment failures. By utilizing wireless hardware, Verdigris collects and transmits electricity consumption data to the cloud, enhancing energy efficiency and facilitating smarter facility operations. Additionally, the company's Building.AI platform offers advanced analytics for enterprise facility managers, enabling real-time monitoring and optimization of power usage at the device level. This machine learning-based software provides critical insights that help organizations improve operational performance and reduce energy costs. Founded in 2010, Verdigris Technologies is headquartered in Moffett Field, California.

Pivot Bio

Series A in 2016
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Blue River Technology

Series B in 2015
Blue River Technology Inc. specializes in developing advanced computer vision and robotics for agricultural applications. Founded in 2011 by Stanford University alumni, the company is known for its innovative See & Spray machines, which utilize precise observation to selectively target and treat individual plants in a field. This technology allows for the targeted application of herbicides, significantly reducing chemical usage and enabling farmers to choose herbicides that suit their needs while enhancing economic efficiency. By offering an automated solution that is suitable for both organic farming and fields with chemical-resistant weeds, Blue River is transforming crop protection practices. The company is headquartered in Sunnyvale, California, with additional offices in Salinas and Yuma, and became a subsidiary of Deere & Company in 2017.

Ginkgo Bioworks

Series B in 2015
Ginkgo Bioworks, founded in 2008 and based in Boston, Massachusetts, specializes in biological engineering by designing, developing, and licensing custom microbes and organisms. The company focuses on discovering and producing a variety of molecules for applications in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, Ginkgo Bioworks offers probiotic bacteria aimed at protecting against harmful infections and creates libraries of molecules for various uses. Its market reach includes sectors such as cultured ingredients, carbon mitigation, probiotics, and natural product discovery.

Zymergen

Series A in 2015
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. The company integrates automation, machine learning, and genomics to enhance its platform, which aids in optimizing microbial strains and improving the efficiency of production processes. By leveraging big data and artificial intelligence, Zymergen collaborates with clients to engineer novel molecules from microbes, thereby advancing product development. Founded in 2013 and headquartered in Emeryville, California, Zymergen also has offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, enabling it to serve a global clientele effectively.

Atomwise

Seed Round in 2015
Atomwise, Inc. specializes in deep learning artificial intelligence technology aimed at small molecule drug discovery. The company leverages its proprietary AI platform, AtomNet, which contains over 16 billion molecules for virtual screening, to enhance the speed and accuracy of drug discovery processes. This technology employs a statistical approach to predict the binding of small molecules to proteins, aiding in drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise collaborates on numerous projects each year with major pharmaceutical and agrochemical companies, as well as over 200 universities and hospitals across 40 countries. Founded in 2012 and based in San Francisco, Atomwise was previously known as Chematria, Inc. before rebranding in 2015.

Ginkgo Bioworks

Series A in 2015
Ginkgo Bioworks, founded in 2008 and based in Boston, Massachusetts, specializes in biological engineering by designing, developing, and licensing custom microbes and organisms. The company focuses on discovering and producing a variety of molecules for applications in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, Ginkgo Bioworks offers probiotic bacteria aimed at protecting against harmful infections and creates libraries of molecules for various uses. Its market reach includes sectors such as cultured ingredients, carbon mitigation, probiotics, and natural product discovery.

Strateos

Series A in 2015
Strateos operates a robotic cloud laboratory that automates chemistry, biology, and tissue analysis to enhance drug discovery processes. By integrating advanced robotics, control systems, and sophisticated imaging and analytics software, Strateos allows pharmaceutical companies to discover new drug candidates more efficiently. The company emerged from a merger between Transcriptic, known for its pioneering robotic cloud laboratory platform, and 3Scan, which specialized in using automation and machine learning to analyze tissue samples. This combination enables Strateos to provide a comprehensive suite of technologies designed to streamline the drug discovery and early development phases. By transforming life science methodologies into data-driven processes, Strateos aims to create a more efficient and cost-effective approach to scientific research, positioning itself as a valuable partner to biotechnology firms seeking to innovate in the field.

Pivot Bio

Seed Round in 2014
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Blue River Technology

Series A in 2014
Blue River Technology Inc. specializes in developing advanced computer vision and robotics for agricultural applications. Founded in 2011 by Stanford University alumni, the company is known for its innovative See & Spray machines, which utilize precise observation to selectively target and treat individual plants in a field. This technology allows for the targeted application of herbicides, significantly reducing chemical usage and enabling farmers to choose herbicides that suit their needs while enhancing economic efficiency. By offering an automated solution that is suitable for both organic farming and fields with chemical-resistant weeds, Blue River is transforming crop protection practices. The company is headquartered in Sunnyvale, California, with additional offices in Salinas and Yuma, and became a subsidiary of Deere & Company in 2017.

Strateos

Seed Round in 2014
Strateos operates a robotic cloud laboratory that automates chemistry, biology, and tissue analysis to enhance drug discovery processes. By integrating advanced robotics, control systems, and sophisticated imaging and analytics software, Strateos allows pharmaceutical companies to discover new drug candidates more efficiently. The company emerged from a merger between Transcriptic, known for its pioneering robotic cloud laboratory platform, and 3Scan, which specialized in using automation and machine learning to analyze tissue samples. This combination enables Strateos to provide a comprehensive suite of technologies designed to streamline the drug discovery and early development phases. By transforming life science methodologies into data-driven processes, Strateos aims to create a more efficient and cost-effective approach to scientific research, positioning itself as a valuable partner to biotechnology firms seeking to innovate in the field.

Zymergen

Seed Round in 2014
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. The company integrates automation, machine learning, and genomics to enhance its platform, which aids in optimizing microbial strains and improving the efficiency of production processes. By leveraging big data and artificial intelligence, Zymergen collaborates with clients to engineer novel molecules from microbes, thereby advancing product development. Founded in 2013 and headquartered in Emeryville, California, Zymergen also has offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, enabling it to serve a global clientele effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.